Multiple dose kinetics of spironolactone and canrenoate-potassium in cardiac and hepatic failure
- 1 May 1974
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 7 (3) , 195-200
- https://doi.org/10.1007/bf00560381
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Molecular modifications of anti-aldosterone compounds: Effects on affinity of spirolactones for renal aldosterone receptorsBiochemical Pharmacology, 1974
- Direkte positiv-inotrope Herzwirkung von Aldactone (Spironolacton, Canrenoat-Kalium)Deutsche Medizinische Wochenschrift (1946), 1972
- Isolation and identification of novel sulfur-containing metabolites of spironolactone (Aldactone®)Steroids, 1972
- Fluorometric Microassay for Spironolactone and Its Metabolites in Biological FluidsJournal of Pharmaceutical Sciences, 1972
- Plasma Levels of Spirolactones in the DogJournal of Pharmaceutical Sciences, 1972
- Spironolactone—a weak enzyme inducer in manJournal of Pharmacy and Pharmacology, 1972
- Positiv-inotrope Herzwirkung von Aldadien-Kalium (Aldactone pro injectione)Klinische Wochenschrift, 1971
- Pharmacokinetic and Metabolic Fate of Potassium Canrenoate (SC-14266) in ManJournal of Pharmaceutical Sciences, 1971
- The influence of spironolactone on its own-biotransformationSteroids, 1970
- A comparison of the use of Aldactone and Aldactone A in the treatment of hepatic ascitesGut, 1963